<code id='A8CF0430E3'></code><style id='A8CF0430E3'></style>
    • <acronym id='A8CF0430E3'></acronym>
      <center id='A8CF0430E3'><center id='A8CF0430E3'><tfoot id='A8CF0430E3'></tfoot></center><abbr id='A8CF0430E3'><dir id='A8CF0430E3'><tfoot id='A8CF0430E3'></tfoot><noframes id='A8CF0430E3'>

    • <optgroup id='A8CF0430E3'><strike id='A8CF0430E3'><sup id='A8CF0430E3'></sup></strike><code id='A8CF0430E3'></code></optgroup>
        1. <b id='A8CF0430E3'><label id='A8CF0430E3'><select id='A8CF0430E3'><dt id='A8CF0430E3'><span id='A8CF0430E3'></span></dt></select></label></b><u id='A8CF0430E3'></u>
          <i id='A8CF0430E3'><strike id='A8CF0430E3'><tt id='A8CF0430E3'><pre id='A8CF0430E3'></pre></tt></strike></i>

          fashion

          fashion

          author:knowledge    Page View:33
          U.S. Sen. Bernie Sanders (I-VT) speaks to the media outside of the White House on July 17, 2023 in Washington, DC – politics coverage from STAT
          Sen. Bernie Sanders (I-Vt.) added three drug shortage measures to a pandemic-preparedness bill that his committee will consider Thursday. Kevin Dietsch/Getty Images

          WASHINGTON — Senate health committee Chair Bernie Sanders (I-Vt.) added three drug shortage measures to a pandemic-preparedness bill that his committee will consider Thursday. Only one of them, however, would grant the Food and Drug Administration new authorities to tackle the issue.

          Congress is under pressure to stem drug shortages amid reports of doctors rationing chemotherapies and other essential medicines.

          advertisement

          The new measure would require drug companies to tell the FDA the volume of ingredients they buy from each of their suppliers. Current law requires companies to disclose from whom they buy ingredients, but they don’t need to share how much of the ingredients they source from suppliers.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          JPM 2024: Verve Therapeutics looks to mainstream genome editing
          JPM 2024: Verve Therapeutics looks to mainstream genome editing

          VerveTherapeuticsCEOSekarKathiresanVerveSANFRANCISCO—Thepromiseofgenomeeditinghasgivenrisetopotentia

          read more
          Hollywood unions extend contract negotiations for actors
          Hollywood unions extend contract negotiations for actors

          1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

          read more

          UHS says company favors patients whose insurance pays more

          Thefinancechiefofthecountry’slargestprivatepsychiatrichospitaloperator,UHS,madeabluntstatementtoday: